MUMBAI, 25 JANUARY, 2023 (GPN): Undoubtedly travel has been widely regarded as a physically healthy and mental pursuit. Many research studies claim it improves the quality of life of people with medical conditions and disabilities….
MUMBAI, 23 JANUARY, 2023 (GPN): OMRON Healthcare India, the Indian arm of the global leader in home blood pressure monitoring and solutions for cardiovascular disease management, has launched a new communication campaign called, ‘Life on…
NATIONAL, 18 JANUARY, 2023 (GPN): Kokilaben Dhirubhai Ambani Hospital (Kokilaben Hospital), India’s leading Multispecialty Healthcare Institute, today announced its expansion to serve patients in Central India with the opening of a state-of-the-art tertiary care hospital…
Collaboration to focus on crash analysis, trauma care training, and research and dissemination DELHI, 18 JANUARY, 2023 (GPN): To advance road safety and emergency medical care across India, the All-India Institute of Medical Sciences, Rishikesh…
राष्ट्रीय, 18 जानेवारी २०२३ (GPN): भारतातील अग्रगण्य मल्टीस्पेशालिटी हेल्थकेअर इन्स्टिट्यूट असलेल्या कोकिलाबेन धीरूभाई अंबानी हॉस्पिटल (कोकिलाबेन हॉस्पिटल)ने आज मध्यप्रदेश मधील इंदौर येथे एक अत्याधुनिक सेवा रुग्णालय सुरू करून मध्य भारतातील रुग्णांना सेवा देण्यासाठी आपल्या विस्ताराची घोषणा…
First-in-world to launch the drug in Tablet Dosage Form on par with innovator for better patient compliance& treatment outcome. HYDERABAD, 18th JANUARY, 2023 (GPN): MSN Group, one of the fastest-growing, research-based fully integrated pharmaceutical companies…
MUMBAI, 17 JANUARY, 2023 (GPN): Blue Jet Healthcare Limited, a specialty pharmaceutical and healthcare ingredient and intermediate company, offering niche products targeted towards innovator pharmaceutical companies and multi-national generic pharmaceutical companies has received final observation from the…
MUMBAI, 16 JANUARY, 2023 (GPN): Mumbai Oncocare Centre (MOC), a Chain of Cancer Daycare Centers and a unit of Cellcure Cancer Center Pvt Ltd announced this Saturday that it has raised up to $10 million…
CINRYZE™ is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE. Among adult HAE patients, 51% miss at least one day of work (mean 3.3 days),…
Apollo Hospitals will organize the 9th edition of the International Patient Safety Conference (IPSC) along with the 10th International Conference on Transforming Healthcare with Information Technology (THIT) on the 13th and 14th of February 2023 in New Delhi, India…
